Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models

This publication has 23 references indexed in Scilit:

• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
  Science, 2020
• A new coronavirus associated with human respiratory disease in China
  Nature, 2020
• Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
  The Lancet, 2020
• Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin
  Molecular Therapy Nucleic Acids, 2019
• Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
  Molecular Therapy, 2018
• Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
  Proceedings of the National Academy of Sciences, 2017
• Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
  PLOS ONE, 2016
• Rapidly produced SAM ^® vaccine against H7N9 influenza is immunogenic in mice
  Emerging Microbes & Infections, 2013
• Nonviral delivery of self-amplifying RNA vaccines
  Proceedings of the National Academy of Sciences, 2012
• The spike protein of SARS-CoV — a target for vaccine and therapeutic development
  Nature Reviews Microbiology, 2009